The Oncology Institute, Inc. (TOI)

NASDAQ: TOI · IEX Real-Time Price · USD

1.150

-0.030 (-2.54%)

At close: Apr 26, 2024, 4:00 PM

1.160

+0.010 (0.87%)

After-hours: Apr 26, 2024, 6:53 PM EDT

The Oncology Institute Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	85	150	119	714	311
Market Cap Growth	-	26.04%	-83.29%	130.01%	-
Enterprise Value	122	187	154	599	316
PE Ratio	-2.22	-2.22	1755.35	-67.20	-21.68
PS Ratio	0.26	0.46	0.47	3.52	1.66
PB Ratio	1.50	2.64	0.97	6.86	11.05
P/FCF Ratio	-3.68	-3.68	-1.77	-20.10	-452.62
P/OCF Ratio	-4.14	-4.14	-1.93	-21.85	611.22
EV/Sales Ratio	0.38	0.58	0.61	2.95	1.69
EV/EBITDA Ratio	-3.39	-3.39	18.48	-78.45	-28.03
EV/EBIT Ratio	-3.06	-3.06	39.35	-54.58	-21.87
EV/FCF Ratio	-4.58	-4.58	-2.28	-16.87	-461.27
Debt / Equity Ratio	2.10	2.10	0.88	0.00	0.42
Debt / EBITDA Ratio	-2.17	-2.17	13.01	-0.02	-1.06
Debt / FCF Ratio	-2.93	-2.93	-1.61	-0.01	-17.39
Quick Ratio	3.62	3.62	3.84	4.58	0.81
Current Ratio	4.13	4.13	4.39	5.17	1.04
Asset Turnover	1.45	1.45	1.07	1.51	0.99
Interest Coverage	-9.02	-9.02	0.96	-34.31	-41.69
Return on Equity (ROE)	-87.00%	-87.00%	0.10%	-16.10%	-132.90%
Return on Assets (ROA)	-30.40%	-30.40%	0.00%	-7.90%	-7.50%
Return on Capital (ROIC)	-43.59%	-43.59%	-35.42%	-43.95%	-20.48%
Earnings Yield	-79.43%	-45.12%	0.06%	-1.49%	-4.61%
FCF Yield	-47.84%	-27.17%	-56.37%	-4.97%	-0.22%
Buyback Yield / Dilution	8.51%	8.51%	-21.70%	-12.03%	-491.18%
Total Shareholder Return	8.51%	8.51%	-21.70%	-12.03%	-491.18%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).